HIV post-exposure prophylaxis (PEP)

BMJ. 2018 Nov 29:363:k4928. doi: 10.1136/bmj.k4928.

Authors

Mark J Siedner^{1

2

3}, Ethan Tumarkin⁴, Isaac I Bogoch^{4

5}

Affiliations

¹ Harvard Medical School, Boston, MA, USA.
² Massachusetts General Hospital, Boston, MA, USA.
³ Mbarara University of Science and Technology, Mbarara, Uganda.
⁴ Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
⁵ Divisions of General Internal Medicine and Infectious Diseases, Toronto General Hospital, University Health Network, Toronto, Ontario.

PMID: 30498074
DOI: 10.1136/bmj.k4928

No abstract available

MeSH terms

Anti-HIV Agents / therapeutic use*
Female
HIV Infections / prevention & control*
Health Knowledge, Attitudes, Practice
Humans
Male
Post-Exposure Prophylaxis*
Practice Guidelines as Topic
Referral and Consultation*
Risk Assessment
Risk-Taking
Unsafe Sex

Substances

Anti-HIV Agents